Dibotermin Alfa News
Dibotermin Alfa currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for Dibotermin Alfa with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Inductos is indicated for single level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non operative...
- Evidence level: L5
- Predicted indications (12):
- tibia fracture (50.0%)
- intervertebral disc degenerative disorder (50.0%)
- esotropia (100.0%)
- HER2 positive breast carcinoma (99.9%)
- normal breast-like subtype of breast carcinoma (99.8%)
- progesterone-receptor positive breast cancer (99.8%)
- breast tumor luminal A or B (99.8%)
- progesterone-receptor negative breast cancer (99.8%)
- non-syndromic esophageal malformation (99.5%)
- multifocal choroiditis (99.2%)
- atypical coarctation of aorta (99.2%)
- anemia of prematurity (98.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.